메뉴 건너뛰기




Volumn 108, Issue 5, 2013, Pages 859-860

Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): The missing term in the literature

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIINFLAMMATORY BOWEL DISEASE DRUG; GOLD; MERCAPTOPURINE; METHOTREXATE; PENICILLAMINE; UNCLASSIFIED DRUG;

EID: 84877276662     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.53     Document Type: Letter
Times cited : (18)

References (8)
  • 1
    • 84870857072 scopus 로고    scopus 로고
    • Decreasing colectomy rates for ulcerative colitis: A population-based time trend study
    • Kaplan GG, Seow CH, Ghosh S et al. Decreasing colectomy rates for ulcerative colitis: a population-based time trend study . Am J Gastroenterol 2012; 107: 1879-87.
    • (2012) Am J Gastroenterol , vol.107 , pp. 1879-1887
    • Kaplan, G.G.1    Seow, C.H.2    Ghosh, S.3
  • 2
    • 77955096659 scopus 로고    scopus 로고
    • Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): A study of changes in medical treatment and surgical resection rates
    • Ramadas AV, Gunesh S, Thomas GA et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates . Gut 2010; 59: 1200-6.
    • (2010) Gut , vol.59 , pp. 1200-1206
    • Ramadas, A.V.1    Gunesh, S.2    Thomas, G.A.3
  • 3
    • 55449098725 scopus 로고    scopus 로고
    • Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: Results from the CHARM study
    • Feagan BG, Panaccione R, Sandborn WJ et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study . Gastroenterology 2008; 135: 1493-9.
    • (2008) Gastroenterology , vol.135 , pp. 1493-1499
    • Feagan, B.G.1    Panaccione, R.2    Sandborn, W.J.3
  • 4
    • 70349418632 scopus 로고    scopus 로고
    • Colectomy rate comparison aft er treatment of ulcerative colitis with placebo or infl iximab
    • Sandborn WJ, Rutgeerts P, Feagan BG et al. Colectomy rate comparison aft er treatment of ulcerative colitis with placebo or infl iximab. Gastroenterology 2009; 137: 1250-60.
    • (2009) Gastroenterology , vol.137 , pp. 1250-1260
    • Sandborn, W.J.1    Rutgeerts, P.2    Feagan, B.G.3
  • 5
    • 79958228566 scopus 로고    scopus 로고
    • Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
    • Peyrin-Biroulet L, Oussalah A, Williet N et al. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease . Gut 2011; 60: 930-6.
    • (2011) Gut , vol.60 , pp. 930-936
    • Peyrin-Biroulet, L.1    Oussalah, A.2    Williet, N.3
  • 6
    • 0017089190 scopus 로고
    • Cyclophosphamide, gold and penicillamine-disease-modifying drugs in rheumatoid arthritis-tailored dosage and ultimate success
    • Gumpel JM . Cyclophosphamide, gold and penicillamine-disease-modifying drugs in rheumatoid arthritis-tailored dosage and ultimate success . Rheumatol Rehabil 1976; 15: 217-20.
    • (1976) Rheumatol Rehabil , vol.15 , pp. 217-220
    • Gumpel, J.M.1
  • 7
    • 0020973631 scopus 로고
    • Radiographic evaluation of the course of articular disease
    • Sharp JT . Radiographic evaluation of the course of articular disease . Clin Rheum Dis 1983; 9: 541-57.
    • (1983) Clin Rheum Dis , vol.9 , pp. 541-557
    • Sharp, J.T.1
  • 8
    • 0034735842 scopus 로고    scopus 로고
    • Infl iximab and methotrexate in the treatment of rheumatoid arthritis. Antitumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group
    • Anti-tumor necrosis factor trial in rheumatoid arthritis with Concomitant Therapy Study Group
    • Lipsky PE, van der Heijde DM, St Clair EW et al. Anti-tumor necrosis factor trial in rheumatoid arthritis with Concomitant Therapy Study Group. Infl iximab and methotrexate in the treatment of rheumatoid arthritis. Antitumor necrosis factor trial in rheumatoid arthritis with Concomitant Therapy Study Group . N Engl J Med 2000; 343: 1594-602.
    • (2000) N Engl J Med , vol.343 , pp. 1594-1602
    • Lipsky, P.E.1    Van Der Heijde, D.M.2    St Clair, E.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.